Marksans Pharma Limited has informed the Exchange about Copy of Newspaper Publication
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma has submitted copies of newspaper advertisements of its unaudited financial results for the quarter ended June 30, 2025, to the stock exchanges. The results were published on August 13, 2025 in Business Standard (English) and Lakshadeep (Marathi) newspapers. This filing is made under Regulation 47 of SEBI's Listing Obligations and Disclosure Requirements, 2015, which mandates listed companies to publish their quarterly financial results in newspapers. The actual financial numbers are not part of this filing — it is purely a confirmation that the newspaper publication requirement has been fulfilled. The communication was signed by Company Secretary Harshavardhan Panigrahi.
This is a routine regulatory compliance filing and has no direct impact on the stock price or shareholders. It simply confirms the company met its obligation to publicly disclose Q1 FY26 results through newspaper advertisements within the prescribed timeline.